13F HOLDINGS REPORT
Logos Global Management LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001172661-24-002503
Total Value
$1.24B
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAREPTA THERAPEUTICS INC | SRPT | 1,200,000 | $155.4M | 12.57% |
| 2 | ALNYLAM PHARMACEUTICALS INC | ALNY | 500,000 | $74.7M | 6.05% |
| 3 | IDEAYA BIOSCIENCES INC | IDYA | 1,500,000 | $65.8M | 5.33% |
| 4 | IMMUNOCORE HLDGS PLC | IMCR | 900,000 | $58.5M | 4.73% |
| 5 | IMMUNOVANT INC | IMVT | 1,775,000 | $57.4M | 4.64% |
| 6 | OCULAR THERAPEUTIX INC | OCUL | 5,811,436 | $52.0M | 4.21% |
| 7 | SAREPTA THERAPEUTICS INC | SRPT | 400,000 | $51.8M | 4.19% |
| 8 | OLEMA PHARMACEUTICALS INC | OLMA | 4,383,875 | $49.6M | 4.02% |
| 9 | DYNE THERAPEUTICS INC | DYN | 1,730,000 | $49.1M | 3.98% |
| 10 | APELLIS PHARMACEUTICALS INC | APLS | 800,000 | $47.0M | 3.81% |
| 11 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,300,000 | $35.0M | 2.83% |
| 12 | SILENCE THERAPEUTICS PLC | SLNCF | 1,476,061 | $31.1M | 2.52% |
| 13 | STRUCTURE THERAPEUTICS INC | GPCR | 720,058 | $30.9M | 2.50% |
| 14 | GERON CORP | GERN | 9,000,000 | $29.7M | 2.40% |
| 15 | CELLDEX THERAPEUTICS INC NEW | CLDX | 650,000 | $27.3M | 2.21% |
| 16 | ENLIVEN THERAPEUTICS INC | ELVN | 1,574,220 | $26.4M | 2.14% |
| 17 | VERA THERAPEUTICS INC | VERA | 575,000 | $24.8M | 2.01% |
| 18 | ANNEXON INC | ANNX | 3,050,000 | $21.9M | 1.77% |
| 19 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,499,999 | $21.2M | 1.72% |
| 20 | DESIGN THERAPEUTICS INC | DSGN | 5,032,501 | $20.3M | 1.64% |
| 21 | AKERO THERAPEUTICS INC | 00973Y108 | 800,000 | $20.2M | 1.64% |
| 22 | STRUCTURE THERAPEUTICS INC | GPCR | 450,000 | $19.3M | 1.56% |
| 23 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,244,960 | $17.5M | 1.42% |
| 24 | CYBIN INC | HELP | 40,000,000 | $16.5M | 1.34% |
| 25 | XENCOR INC | XNCR | 650,000 | $14.4M | 1.16% |
| 26 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,000,000 | $14.1M | 1.14% |
| 27 | CG ONCOLOGY INC | CGON | 300,000 | $13.2M | 1.07% |
| 28 | ENGENE HOLDINGS INC | ENGNW | 800,000 | $12.9M | 1.04% |
| 29 | KYVERNA THERAPEUTICS INC | KYTX | 500,000 | $12.4M | 1.01% |
| 30 | VIRIDIAN THERAPEUTICS INC | VRDN | 700,000 | $12.3M | 0.99% |
| 31 | CULLINAN ONCOLOGY INC | CGEM | 700,000 | $11.9M | 0.97% |
| 32 | IMMATICS N.V | IMTX | 1,000,000 | $10.5M | 0.85% |
| 33 | SPYRE THERAPEUTICS INC | SYRE | 250,000 | $9.5M | 0.77% |
| 34 | FULCRUM THERAPEUTICS INC | FULC | 1,000,000 | $9.4M | 0.76% |
| 35 | LINEAGE CELL THERAPEUTICS IN | 53566P109 | 6,250,000 | $9.3M | 0.75% |
| 36 | PRAXIS PRECISION MEDICINES I | PRAX | 150,000 | $9.2M | 0.74% |
| 37 | APPLIED THERAPEUTICS INC | 03828A101 | 1,350,000 | $9.0M | 0.73% |
| 38 | SYNDAX PHARMACEUTICALS INC | SNDX | 350,000 | $8.3M | 0.67% |
| 39 | TREVI THERAPEUTICS INC | TRVI | 2,200,000 | $7.6M | 0.61% |
| 40 | ANNEXON INC | ANNX | 1,000,000 | $7.2M | 0.58% |
| 41 | CYTOKINETICS INC | CYTK | 100,000 | $7.0M | 0.57% |
| 42 | KURA ONCOLOGY INC | KURA | 300,000 | $6.4M | 0.52% |
| 43 | NEUMORA THERAPEUTICS INC. | NMRA | 382,345 | $6.2M | 0.50% |
| 44 | ATYR PHARMA INC | ATYR | 3,100,000 | $6.0M | 0.49% |
| 45 | JANUX THERAPEUTICS INC | JANX | 150,000 | $5.6M | 0.46% |
| 46 | LARIMAR THERAPEUTICS INC | LRMR | 700,000 | $5.3M | 0.43% |
| 47 | ELEVATION ONCOLOGY INC | 28623U101 | 1,000,000 | $5.1M | 0.42% |
| 48 | NEXTCURE INC | NXTC | 1,925,000 | $4.3M | 0.35% |
| 49 | ALLAKOS INC | 01671P100 | 2,900,000 | $3.7M | 0.30% |
| 50 | UNICYCIVE THERAPEUTICS INC | UNCY | 3,469,927 | $3.0M | 0.24% |
| 51 | BOUNDLESS BIO INC | BOLD | 200,000 | $2.9M | 0.23% |
| 52 | TOURMALINE BIO INC | 89157D105 | 99,208 | $2.3M | 0.18% |
| 53 | COMPASS PATHWAYS PLC | CMPS | 257,980 | $1.8M | 0.15% |
| 54 | IO BIOTECH INC | IOBT | 493,827 | $854,321 | 0.07% |
| 55 | IMMUNIC INC | IMUX | 421,184 | $555,963 | 0.04% |
| 56 | LEAP THERAPEUTICS INC | CYPH | 39,500 | $105,070 | 0.01% |
| 57 | NUVATION BIO INC | NUVB | 66,666 | $22,743 | 0.00% |